The global Cancer Gene Therapy Market was valued at USD 4.07 billion in 2024, expected to reach USD 17.35 billion by 2032 with a CAGR of 19.96%. Factors driving growth include increased cancer malignancy, research on gene therapies, and innovations in gene delivery techniques. Major players include Merck KGaA and GSK plc.
The market is expanding globally beyond primary care, with increased industrial investment and partnerships. The Cancer Gene Therapy Market Report covers key segments like indication, route of administration, vector type, and end-user. North America dominates the market, followed by Asia Pacific. The Asia Pacific market is growing rapidly due to a large patient population and high investment in genomics.
In 2024, the large B-cell lymphoma segment led the market share due to successful CAR-T cell therapies. Intravenous delivery was dominant due to existing therapies. Lentivirus was the key technology for gene therapies, and cancer research institutes played a significant role. North America led the market share in 2024 due to a highly evolved biotechnology ecosystem.
Recent news includes Merck KGaA announcing encouraging data for TGCT therapy and GSK plc acquiring IDRx, Inc. for precision therapeutics development. The upfront consideration for the acquisition includes an immediate cash payment of US$1 billion. The market is expected to continue growing with advancements in gene therapy. The Cancer Gene Therapy Market Analysis & Outlook report offers exclusive sections focusing on cancer incidence & prevalence metrics, gene therapy clinical pipeline insights, therapy type & regional adoption trends, precision oncology prescription analytics, manufacturing & supply chain capacity index, and regulatory and reimbursement frameworks. Access the complete report details at https://www.snsinsider.com/reports/cancer-gene-therapy-market-8135. For more information or customization, contact [email protected].
SNS Insider is a leading market research and consulting agency that provides clients with the knowledge needed to navigate changing circumstances. Utilizing surveys, video talks, and focus groups globally, the company delivers current, accurate market data, consumer insights, and opinions to help clients make confident decisions in the market.
Read more at GlobeNewswire: Cancer Gene Therapy Market to Reach USD 17.35 Billion by